Atlas Trials

Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

Clinical trial NCT04972487 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT04972487
Sponsor
Biogen
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.